Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis

Acta Biomaterialia

Volumn 19, Issue , 2015, Pages 66-75

  Rooney, Peadar ^a   Srivastava, Akshay ^a   Watson, Luke ^a   Quinlan, Leo R ^a   Pandit, Abhay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cytokine; Hyaluronan; Inflammation; Interstitial cystitis; Permeability

Indexed keywords

CONTROLLED DRUG DELIVERY; GENE TRANSFER; INTEGRATED CIRCUITS; ORGANIC ACIDS; PHYSIOLOGY; TARGETED DRUG DELIVERY;

CYTOKINE SECRETIONS; CYTOKINES; EPITHELIAL PERMEABILITY; GLYCOSAMINOGLYCANS; HYALURONAN; INTERSTITIAL CYSTITI; INTERSTITIALS; PERMEABILITY; UROTHELIUM; WOUND HEALING;

HYALURONIC ACID;

GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 6; INTERLEUKIN 8; IL6 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTERSTITIAL CYSTITIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; UROTHELIUM; CYSTITIS, INTERSTITIAL; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; MATERIALS TESTING; PATHOLOGY;

CELL MEMBRANE PERMEABILITY; CYSTITIS, INTERSTITIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; INTERLEUKIN-6; INTERLEUKIN-8; MATERIALS TESTING; TIGHT JUNCTIONS; UROTHELIUM;

EID: 84928421604     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.02.030     Document Type: Article

References (51)

1. M.B. Chancellor A Multidisciplinary consensus meeting on ic/pbs: Outcome of the consensus meeting on interstitial cystitis/painful bladder syndrome, February 10, 2007, Washington, DC Rev Urol 9 2007 81 83
2. P.J. Held, P.M. Hanno, A.J. Wein, M.V. Pauly, and M.A. Cahn Epidemiology of interstitial cystitis: 2. Interstitial cystitis 1990 Springer London pp. 29-40
3. P.M. Hanno, D.A. Burks, J.Q. Clemens, R.R. Dmochowski, D. Erickson, and M.P. Fitzgerald AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome J Urol 185 2011 2162 2170
4. M.T. Rosenberg, and M. Hazzard Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office J Urol 174 2005 2231 2234
5. R.E. Hurst, K. Patton, B. Roy, K.W. Min, R.W. Veltri, and G. Marley A deficit of chondroitin on the bladder urothelium J Urol 4295 1996 817 821
6. D.C. Wei, V.A. Politano, M.G. Selzer, and V.B. Lokeshwar The association of elevated urinary total to sulfated glycosaminoglycan ratio and high molecular mass hyaluronic acid with interstitial cystitis J Urol 163 2000 1577 1583
7. D.R. Erickson, M. Sheykhnazari, S. Ordille, and V.P. Bhavanandan Increased urinary hyaluronic acid and interstitial cystitis J Urol 160 1998 1282 1284
8. V.B. Lokeshwar, M.G. Selzer, W.H. Cerwinka, M.-F.L. Gomez, R.R. Kester, and D.E. Bejany Urinary uronate and sulfated glycosaminoglycan levels: Markers for interstitial cystitis severity J Urol 174 2005 344 349
9. R.E. Hurst, C.L. Parsons, J.B. Roy, and J.L. Young Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis J Urol 149 1993 31 35
10. J.C. Nickel, R.B. Egerdie, G. Steinhoff, B. Palmer, and P. Hanno A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome Urology 76 2010 804 809
11. R.M. Moldwin, R.J. Evans, E.J. Stanford, and M.T. Rosenberg Rational approaches to the treatment of patients with interstitial cystitis Urology 69 2007 73 81
12. E. Kallestrup, S. Jørgensen, J. Nordling, and T. Hald Treatment of interstitial cystitis with Cystistat®, a hyaluronic acid product Scand J Urol Nephrol 39 2005 143 147
13. C.L. Parsons, J.D. Lilly, and P. Stein Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis) J Urol 145 1991 732 735
14. G. Slobodov, M. Feloney, C. Gran, K.D. Kyker, R.E. Hurst, and D.J. Culkin Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis J Urol 171 2007 945 948
15. K. Ghazi, U. Deng-Pichon, J.-M. Warnet, and P. Rat Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: Role of molecular weight PLoS One 7 2012 e48351
16. S. Keay, P. Kaczmarek, C.-O. Zhang, K. Koch, Z. Szekely, and J.J. Barchi Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis/painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor Chem Biol Drug Des 77 2011 421 430
17. N. Kirschner, M. Haftek, C.M. Niessen, M.J. Behne, M. Furuse, and I. Moll CD44 regulates tight-junction assembly and barrier function J Invest Dermatol 131 2011 932 943
18. S. Keay, J.W. Warren, C.O. Zhang, L.M. Tu, D.A. Gordon, and K.E. Whitmore Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients J Urol 162 1999 1487 1489
19. C.-O. Zhang, J.-Y. Wang, K.R. Koch, and S. Keay Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis J Urol 174 2005 2382 2387
20. T.Y. Ma, G.K. Iwamoto, N.T. Hoa, V. Akotia, A. Pedram, and M. Boivin TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation Am J Physiol Gastrointest Liver Physiol 286 2004 G367 G376
21. P.R. Gibson Increased gut permeability in Crohn's disease: Is TNF the link? Gut 53 2004 1724 1725
22. N. Parameswaran, and S. Patial Tumor necrosis factor-α signaling in macrophages Crit Rev Eukaryot Gene Expr 20 2010 87 103
23. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ 10 2003 45 65
24. H.-C. Kuo, and H.-T. Liu Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease PLoS ONE 7 2012 e44687
25. M. Lotz, P. Villiger, T. Hugli, J. Koziol, and B.L. Zuraw Interleukin-6 and interstitial cystitis J Urol 152 1994 869 873
26. L.R. Koskela, T. Thiel, I. Ehrén, P.J. De Verdier, and N.P. Wiklund Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis J Urol 180 2008 737 741
27. D.R. Erickson, J.E. Tomaszewski, A.R. Kunselman, C.M. Stetter, K.M. Peters, and E.S. Rovner Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome J Urol 179 2008 1850 1856
28. L.M. Lamale, S.K. Lutgendorf, M.B. Zimmerman, and K.J. Kreder Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis Urology 68 2006 702 706
29. M. Green, A. Filippou, G. Sant, and T.C. Theoharides Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis Urology 63 2004 688 693
30. S.M. Martins, D.J. Darlin, P.M. Lad, and P.E. Zimmern Interleukin-1B: A clinically relevant urinary marker J Urol 151 1994 1198 1201
31. D.R. Erickson, S.X. Xie, V.P. Bhavanandan, M.A. Wheeler, R.E. Hurst, and L.M. Demers A comparison of multiple urine markers for interstitial cystitis J Urol 167 2002 2461 2469
32. V. Tyagi, K.M. Peters, M. Chancellor, K. Killinger, J. Nirmal, and P. Tyagi Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis J Urol 187 2012 2243 2248
33. Y.-S. Lv, Y.-S. Yao, M.-E. Lin, L. Rong, B.-H. Deng, and J. Huang Interleukin-6 levels in female rats with protamine sulfate-induced chronic cystitis treated with hyaluronic acid Int J Urol 20 2013 1017 1022
34. S. Tseng-Rogenski, and M. Liebert Interleukin-8 is essential for normal urothelial cell survival Am J Physiol Renal Physiol 297 2009 F816 F821
35. K.M. Peters, A.C. Diokno, and B.W. Steinert Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder? Urology 54 1999 450 453
36. R. Soler, H. Bruschini, J.C. Truzzi, J.R. Martins, N.O. Camara, and M.T. Alves Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis Int Braz J Urol 34 2008 503 511 [discussion 511]
37. C.A. Buffington, J.L. Blaisdell, S.P. Binns, and B.E. Woodworth Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis J Urol 155 1996 1801 1804
38. D.R. Erickson, S. Ordille, A. Martin, and V.P. Bhavanandan Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis J Urol 157 1997 61 64
39. T. Akçay, and D. Konukoʇlu Glycosaminoglycans excretion in interstitial cystitis Int Urol Nephrol 31 1999 431 435
40. D.A. Janssen, X.M. van Wijk, K.C. Jansen, T.H. van Kuppevelt, J.P. Heesakkers, and J.A. Schalken The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier J Urol 189 2013 336 342
41. W. Wang, S. Uzzau, S.E. Goldblum, and A. Fasano Human zonulin, a potential modulator of intestinal tight junctions J Cell Sci 113 Pt 24 2000 4435 4440
42. A. Fasano Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin Ann N Y Acad Sci 915 2000 214 222
43. C. Cheng, A. Rosamilia, and M. Healey Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: A prospective observational study Int Urogynecol J 23 2012 1361 1366
44. J.-H. Shie, and H.-C. Kuo Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome BJU Int 108 2011 E136 E141
45. J. Voigt, and V.R. Driver Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: A systematic review and meta-analysis of randomized controlled trials Wound Repair Regen 20 2012 317 331
46. J. Frank, K. Born, J.H. Barker, and I. Marzi In vivo effect of tumor necrosis factor alpha on wound angiogenesis and epithelialization Eur J Trauma 29 2003 208 219
47. T. Markham, R. Mullan, L. Golden-Mason, S. Rogers, B. Bresnihan, and O. FitzGerald Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy J Am Acad Dermatol 54 2006 1003 1012
48. T. Rooney, B. Bresnihan, U. Andersson, M. Gogarty, M. Kraan, and H.R. Schumacher Microscopic measurement of inflammation in synovial tissue: Inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis Ann Rheum Dis 66 2007 1656 1660
49. Y. Garcia, A. Breen, K. Burugapalli, P. Dockery, and A. Pandit Stereological methods to assess tissue response for tissue-engineered scaffolds Biomaterials 28 2007 175 186
50. P. Valent Cytokines involved in growth and differentiation of human basophils and mast cells Exp Dermatol 4 1995 255 259
51. M.C. Smaldone, Y. Vodovotz, V. Tyagi, D. Barclay, B.J. Philips, and N. Yoshimura Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis Urology 73 2009 2